ProShares Global Listed Private Equity ETF
Limited financial coverage for PEX.
Not enough data to compute a meaningful composite — typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available stats still render below.
Price Chart
About the company
PEX is the third launch in the Global Private Equity Segment and is a market-cap-selected and -weighted fund, thus offering plain vanilla exposure to investors. The underlying index tracks 30 qualifying listed private equity companies which were screened based on, among other things, greater relative trading volume. Generally, the fund will invest at least 80% of its total assets in component securities of the index, and will primarily invest in common stocks of domestic and foreign companies (including in large part BDCs for US-domiciled companies) of any size.
- CEO
- Richard L. Van Kirk
- IPO
- 2013
- Employees
- 142
- HQ
- Bethesda, MD, US
Get TickerSpark's AI analysis on PEX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $10.16M
- Div Yield
- 5.65%
- 52W High
- $25.77
- 52W Low
- $20.49
- 50D MA
- $22.78
- 200D MA
- $22.67
- Beta
- 0.80
- RSI (14)
- 38
- Avg Volume
- 1.55K
No earnings-call transcripts are available for PEX yet.
- Free Float
- —
- Shares Outstanding
- 459.95K
- Float Shares
- —
of shares held by institutions
15 13F filers
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Beta Wealth Group, Inc. | 43.66K | ▲ 818 |
| Royal Bank Of Canada | 28.80K | ▼ 2.78K |
| Envestnet Asset Management Inc | 21.78K | ▲ 8.02K |
| Cetera Investment Advisers | 16.38K | 0 |
| Lpl Financial LLC | 12.70K | ▲ 715 |
| Susquehanna International Group, Llp | 12.48K | ▲ 12.48K |
| Rossby Financial, Lcc | 11.97K | ▲ 1.66K |
| Allworth Financial LP | 900 | 0 |
| Osaic Holdings, Inc. | 300 | 0 |
| Ubs Group AG | 276 | ▲ 276 |
| Jacobi Capital Management LLC | 250 | ▲ 250 |
| Global Retirement Partners, LLC | 164 | ▼ 141 |
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Apr 22, 09 | DEUTSCHE BANK AG\ | sell | 189,500 |
| Dec 16, 08 | DEUTSCHE BANK AG\ | sell | 100,000 |
| Apr 17, 08 | DEUTSCHE BANK AG\ | buy | 100,000 |
| Apr 18, 08 | DEUTSCHE BANK AG\ | sell | 100,000 |
| Apr 8, 08 | DEUTSCHE BANK AG\ | other | 0 |
| Jun 7, 08 | DEUTSCHE BANK AG\ | other | 0 |
| Apr 18, 08 | DEUTSCHE BANK AG\ | sell | 100,000 |
| Apr 17, 08 | DEUTSCHE BANK AG\ | other | 0 |
| Jun 7, 07 | VAN NOSTRAND ROBERT L | other | 0 |
| Jun 7, 07 | VAN NOSTRAND ROBERT L | other | 0 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our PEX coverage
Recent articles, reports, and earnings notes.
No research on PEX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate PEX report →Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health Ships PEX010 to UCSF for Phase 1 Trial of Psilocybin in Healthy Older Adults with Low Well-Being
newsfilecorp.com · Nov 17
Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health Ships PEX010 to King's College London
newsfilecorp.com · Nov 9
Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health Ships PEX010 to the University of Southern California for the Expanded Mindfulness Assisted Psychedelic Therapy Trial
newsfilecorp.com · Nov 3
Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health Signs Agreement to Supply PEX010 to Linkoping University for PsiloSAD Trial in Social Anxiety Disorder
newsfilecorp.com · Oct 28
Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health Ships PEX010 to the University of Calgary for Phase 2 Trial of Psilocybin-Assisted Therapy for PTSD in Survivors of Intimate Partner Violence
newsfilecorp.com · Sep 29
Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health Expands Supply Agreement with the University of Chieti-Pescara for PEX010 in the TEMPO Clinical Trial of Psilocybin for Treatment-Resistant Depression in Italy
newsfilecorp.com · Sep 25
Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health Delivers PEX010 to Bruyere Health Research Institute's Phase 3 Trial of Microdose Psilocybin in Palliative Care
newsfilecorp.com · Sep 21
Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health Signs Supply and Licensing Agreement with the Centre for Human Drug Research for PEX010 in a Study of Low and Medium Dose Psilocybin
newsfilecorp.com · Sep 17
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.